TROY EDWARD WILSON - Director at Atrium Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by TROY EDWARD WILSON since 11 Mar 2025

Holdings reported by TROY EDWARD WILSON for Atrium Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 20,000 27 Feb 2026 Direct Common Stock
Common Stock 10,360 26 Feb 2026 Direct
Common Stock 1,371 26 Feb 2026 By family trust

Transactions reported by TROY EDWARD WILSON for Atrium Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.